End-stage renal disease after high-dose carboplatinum in preparation of autologous stem cell transplantation.
Stem cell transplantation is one therapy employed in the management of children with high-risk solid tumors. However, this therapy is not without risk, having been associated with multiple end-organ toxicities. Both acute renal failure and chronic renal insufficiency have been reported in marrow transplant recipients, primarily in the context of the use of calcineurin inhibitors and radiation therapy. This report reviews our experience in managing an adolescent with metastatic Ewing's sarcoma who developed rapid progression to end-stage renal disease following a pretransplant conditioning regimen with high-dose carboplatinum. She had not received radiation or prior cisplatinum therapy. The possible reasons for the patient's highly unusual course and recommendations on ways to prevent this complication are discussed.
Butani
Lavjay
L
Section of Pediatric Nephrology, Department of Pediatrics, University of California, Davis Medical Center, Sacramento 95817, USA. lavjay.butani@ucdmc.ucdavis.edu
West
Daniel C
DC
Taylor
Douglas S
DS
D000293:Adolescent; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000628:therapy*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000139:chemically induced* / Q000150:complications; D036102:Peripheral Blood Stem Cell Transplantation; D012512:Sarcoma, Ewing / Q000628:therapy*; D019172:Transplantation Conditioning / Q000009:adverse effects*; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents; D016190:Carboplatin